Physician profile
Gregory D Roulette
NPI 1295909174
$4,572.67
in general payments reported to CMS, 2019-2025
12 companies · $3,266 in 2025
The $3,266 reported for 2025 was more than what 96% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $901 · 2020: $62.30 · 2023: $72.63 · 2024: $271 · 2025: $3,266.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,180 · Food and Beverage: $293 · Education: $137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,180.00 |
| Food and Beverage | $292.50 |
| Education | $137.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Roche Diagnostics International LTD | $3,180.00 | 2025 | |
| Intuitive Surgical, INC. | $810.99 | 2019 | |
| Medical Device Business Services, INC. | $271.20 | 2024 | Ethicon |
| Sumitomo Pharma America, INC. | $72.63 | 2023 | Myfembree |
| Amag Pharmaceuticals, INC. | $57.92 | 2019 | |
| Exeltis, USA INC. | $39.29 | 2020 | |
| Medtronic, INC. | $33.13 | 2025 | Minimed 780g, Inpen Smart Insulin Delivery System |
| Dexcom, INC. | $31.84 | 2025 | Dexcom G6 Transmitter |
| Abbvie INC. | $23.01 | 2020 | |
| Insulet Corporation | $20.71 | 2025 | Omnipod |
| Merck Sharp & Dohme LLC | $16.77 | 2019 | |
| Lupin INC. | $15.18 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Roulette listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.